AI assistant
Sending…
SAB Biotherapeutics, Inc. — Director's Dealing 2021
Oct 23, 2021
34961_dirs_2021-10-22_bc1dd935-af31-4d4a-9a7d-6a729ca1ddd0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Big Cypress Acquisition Corp. (SABS)
CIK: 0001833214
Period of Report: 2021-10-22
Reporting Person: Link David Charles (Director)
More from SAB Biotherapeutics, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Mar 31
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5